CI
NDRM

Cowen Inc’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Cowen Inc’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-64,000
Closed -$2.86M – 407
2017
Q3 		$2.86M Buy
+64,000
New +$2.35M 0.1% 77
2016
Q1 		– Sell
-10,100
Closed -$172K – 424
2015
Q4 		$172K Hold
10,100
– – 0.01% 266
2015
Q3 		$209K Buy
+10,100
New +$207K 0.01% 212

Other funds holding NDRM

VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return
OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Cowen Inc's NDRM Position: Q4 2017 in Review

Cowen Inc sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 64,000 shares — an estimated $2.86M sold.

Cowen Inc first reported a position in NDRM in Q3 2015 and held it in 3 quarters. The position peaked at $2.86M in Q3 2017. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

  • Cowen Inc reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • Cowen Inc sold 64,000 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $2.86M.
  • Cowen Inc first reported a position in NeuroDerm Ltd. Ordinary Shares in Q3 2015 and held it in 3 quarters.
  • Cowen Inc's NeuroDerm Ltd. Ordinary Shares position peaked at $2.86M in Q3 2017.
  • 5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on Cowen Inc's 13F filing for Q4 2017, filed 15 Feb 2018.